Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Approvable letter for zoledronic acid in Paget's disease

Feb. 27, 2006

BioPartners receives positive Europe opinion for Valtropin

Feb. 27, 2006

CHMP recommends European approval of Preotact

Feb. 27, 2006

Agents with potential utility in the treatment of metabolic disorders described in recent patents

Feb. 27, 2006

Study results further support utility of Niaspan

Feb. 27, 2006

Pharmacopeia and Biovitrum collaboration advances new class of compounds

Feb. 24, 2006

Farnesyltransferase inhibitors for progeria syndromes / News in Context

Feb. 24, 2006

Oral Telintra studied in phase I/IIa study for MDS

Feb. 24, 2006

Glycogen phosphorylase inhibitor PSN-357 begins phase IIa trial

Feb. 23, 2006

Savient explores strategic options for Rosemont Pharmaceuticals

Feb. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...